Epilepsy in the elderly

Neurology

Volumn 55, Issue 5 SUPPL. 1, 2000, Pages

  Ramsay, R E ^a   Pryor, F ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Adverse effects; Antiepileptic drugs; Elderly

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TIAGABINE; VALPROIC ACID;

AGED; AGING; ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; EPILEPSY; HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

AGED; AGING; ANTICONVULSANTS; EPILEPSY; HUMANS; MIDDLE AGED;

EID: 0033812773     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. The Gulstonian lectures on epilepsy
2. Effect of age on epilepsy and its treatment: Results from the VA Cooperative Study
3. Epileptic seizures in nonembolic cerebral infarction
4. Epileptic seizures in cerebral arterial occlusive disease
5. The electroencephalogram as a predictor of seizures following cerebral infarction
6. Cerebral embolization: Prospective clinical analysis of 42 cases
7. Epilepsy in cerebral vascular disease
8. The frequency of epilepsy preceding stroke. Case-control study in 230 patients
9. Epileptic seizures in elderly patients with dementia
10. Seizure disorders: The changes with age
11. Morbus Alzheimer and Morbus Pick: A genetic, clinical and pathoanatomical study
12. Predicting outcomes after head injury
13. Misleading presentation of epilepsy in elderly people
14. Status epilepticus in children, adults, and the elderly
15. Status epilepticus: The next decade
16. Efficacy of intravenous phenytoin in the treatment of status epilepticus: Kinetics of central nervous system penetration
17. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondary generalized tonic-clonic seizures in adults
18. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures
19. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
20. Use of phenytoin and carbamazepine in treatment of epilepsy
21. Carbamazepine: Absorption, distribution, and excretion
22. Gabapentin: Chemistry, absorption, distribution, and excretion
23. Lamotrigine: Absorption, distribution, and excretion
24. Phenytoin: Absorption, distribution, and excretion
25. Valproic acid: Absorption, distribution, and excretion
26. Valproic acid: Chemistry and biotransformation
27. Antiepileptics in the elderly: Pharmacoepidemiology and pharmacokinetics
28. Bioavailability of rectally administered lorazepam
29. Fosphenytoin: Pharmacokinetics and tolerance of intramuscular loading doses
30. Pearls for practice: Polypharmacy and the older adult
31. Interference of oral phenytoin absorption by continuous nasogastric feedings
32. Phenytoin and nasogastric feedings
33. The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children
34. Drug stimulated biotransformation of hormonal steroid contraceptives: Clinical implications
35. Warfarin and phenytoin interactions
36. Clinical pharmacology of oral contraceptive steroids
37. Interaction of propoxyphene with carbamazepine
38. Catastrophic neurologic signs due to drug interaction: Tegretol and Darvon
39. Carbamazepine metabolism in humans. Effect of concurrent anticonvulsant therapy
40. Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital
41. Encephalomyelopathy as an idiosyncratic reaction to carbamazepine: A case report
42. Carbamazepine encephalopathy
43. Metabolism of antiepileptic medication: Newborn to elderly
44. Effects of antiepileptic drugs on hormones
45. Hepatotoxic reactions associated with carbamazepine therapy
46. Carbamazepine-induced bradycardia-tachycardia syndrome with pharmacological analysis and concurrent ECG Monitoring
47. Phenytoin-induced nephrotic syndrome
48. Carbamazepine-induced pseudolymphoma and immune dysregulation